Consumption of different pharmaceuticals has increased since the COVID-19 pandemic.
Some health institutions worldwide approved the use of drugs such as ivermectin …

Hydroxychloroquine (HCQ) has been used for rheumatological diseases such as systemic
lupus erythematous and rheumatoid arthritis and demonstrated to improve clinical symptoms …

ABSTRACT HCQ an antimalarial drug is one of the most in-demand medications globally
since COVID-19 pandemics. To study the controlled release of HCQ in physiological …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of
clinical manifestations and multifactorial etiologies ranging from environmental to genetic …

The aim of this study was to develop an effective controlled drug delivery system based on
alginate beads for the treatment of autoimmune diseases such as Rheumatoid Arthritis (RA) …

Hydroxychloroquine (HCQ) was repurposed for COVID-19 treatment. Subtherapeutic HCQ
lung levels and cardiac toxicity of oral HCQ were overcome by intratracheal (IT) …

An unprecedented rise in the demand for the drug hydroxychloroquine (HCQ) worldwide
and its utilisation has resulted in its upscale manufacturing. Being ecologically persistent …

Abstract On March 11, 2020, the World Health Organization declared the coronavirus
disease pandemic, caused by the SARS-CoV-2 virus. This declaration propelled the drug …

Hydroxychloroquine sulfate (HCQ), an against-COVID-19 drug, is a dangerous organic
compound in wastewater. In this study, 0.6 L of an HCQ solution (50 mg L− 1) was electro …

Background and Objectives: It is known that critical illness and associated neuromuscular
problems begin to appear in patients hospitalized in the intensive care unit (ICU) for more …